Cargando…

Surgical management of pancreatic neuroendocrine neoplasms

Pancreatic neuroendocrine neoplasms are relatively rare entities, representing approximately 1% to 2% of all pancreatic tumors. Owing to their rarity as well as their relatively indolent natural history, treatment approaches are not yet standardized. A formal pancreatic resection is usually mandator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Partelli, Stefano, Maurizi, Angela, Tamburrino, Domenico, Crippa, Stefano, Pandolfi, Silvia, Falconi, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	King Faisal Specialist Hospital and Research Centre 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074938/ https://www.ncbi.nlm.nih.gov/pubmed/24658547 http://dx.doi.org/10.5144/0256-4947.2014.1

Ejemplares similares

Long-Term Pancreatic Functional Impairment after Surgery for Neuroendocrine Neoplasms
por: Andreasi, Valentina, et al.
Publicado: (2019)

Pancreatic cystic neoplasms: What is the most cost-effective follow-up strategy?
por: Maggi, Giulia, et al.
Publicado: (2018)

Diagnostic accuracy of EUS-FNA in the evaluation of pancreatic neuroendocrine neoplasms grading: Possible clinical impact of misclassification
por: Tacelli, Matteo, et al.
Publicado: (2021)

The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer
por: Berardi, Rossana, et al.
Publicado: (2020)

Postoperative Outcomes and Functional Recovery After Preoperative Combination Chemotherapy for Pancreatic Cancer: A Propensity Score-Matched Study
por: Pecorelli, Nicolò, et al.
Publicado: (2019)

Pancreatic fistula after pancreaticoduodenectomy—does surgical technique matter?
por: Crippa, Stefano, et al.
Publicado: (2020)

Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology
por: Crippa, Stefano, et al.
Publicado: (2016)

Impact of Ki67 re-assessment at time of disease progression in patients with pancreatic neuroendocrine neoplasms
por: Panzuto, Francesco, et al.
Publicado: (2017)

EZH2 Inhibition as New Epigenetic Treatment Option for Pancreatic Neuroendocrine Neoplasms (PanNENs)
por: April-Monn, Simon Leonhard, et al.
Publicado: (2021)

Geographical Disparities and Patients’ Mobility: A Plea for Regionalization of Pancreatic Surgery in Italy
por: Balzano, Gianpaolo, et al.
Publicado: (2023)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
por: Mapelli, Paola, et al.
Publicado: (2021)

Diagnostic and Interventional Role of Endoscopic Ultrasonography for the Management of Pancreatic Neuroendocrine Neoplasms
por: Melita, Giuseppinella, et al.
Publicado: (2021)

Feasibility of therapeutic endoscopic ultrasound in the bridge-to-surgery scenario: The example of pancreatic adenocarcinoma
por: Vanella, Giuseppe, et al.
Publicado: (2022)

The Surgical Management of Lung Neuroendocrine Neoplasms
por: Soldath, Patrick, et al.
Publicado: (2023)

Imaging of Pancreatic Neuroendocrine Neoplasms
por: Chiti, Giuditta, et al.
Publicado: (2021)

Duodenal Gastric Metaplasia and Duodenal Neuroendocrine Neoplasms: More Than a Simple Coincidence?
por: Massironi, Sara, et al.
Publicado: (2022)

Extent of Surgery and Implications of Transection Margin Status after Resection of IPMNs
por: Paini, Marina, et al.
Publicado: (2014)

Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making
por: Marchegiani, Giovanni, et al.
Publicado: (2022)

What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review
por: Frey, Samuel, et al.
Publicado: (2021)

Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms
por: Berardi, Rossana, et al.
Publicado: (2018)

Management of Functional Pancreatic Neuroendocrine Neoplasms
por: Magi, Ludovica, et al.
Publicado: (2023)

DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors
por: Cives, Mauro, et al.
Publicado: (2019)

Challenges in High-grade Neuroendocrine Neoplasms and Mixed Neuroendocrine/Non-neuroendocrine Neoplasms
por: La Rosa, Stefano
Publicado: (2021)

Biomarkers for Pancreatic Neuroendocrine Neoplasms (PanNENs) Management—An Updated Review
por: Bocchini, Martine, et al.
Publicado: (2020)

An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
por: Bevere, Michele, et al.
Publicado: (2023)

Imaging presentation of pancreatic neuroendocrine neoplasms
por: Ciaravino, Valentina, et al.
Publicado: (2018)

Surgical Management of Pancreatic Neuroendocrine Tumors
por: Sulciner, Megan L., et al.
Publicado: (2023)

Classification of neuroendocrine neoplasms: lights and shadows
por: La Rosa, Stefano, et al.
Publicado: (2020)

Management of Small Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Current Opinion and Controversies
por: Paik, Woo Hyun, et al.
Publicado: (2022)

Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms
por: Piscopo, Leandra, et al.
Publicado: (2023)

Somatostatin analogs: is one better than other?
por: Rossana, Berardi, et al.
Publicado: (2017)

Preoperative CT image analysis to improve risk stratification for clinically relevant pancreatic fistula after distal pancreatectomy
por: Pecorelli, Nicolò, et al.
Publicado: (2022)

Medical Treatment of Advanced Pancreatic Neuroendocrine Neoplasms
por: Palmieri, Lola-Jade, et al.
Publicado: (2020)

Ampullary Neuroendocrine Neoplasms: Identification of Prognostic Factors in a Multicentric Series of 119 Cases
por: Vanoli, Alessandro, et al.
Publicado: (2022)

Neuroendocrine neoplasms of the esophagus and stomach
por: Mastracci, Luca, et al.
Publicado: (2021)

Clinical Management of Neuroendocrine Neoplasms in Clinical Practice: A Formal Consensus Exercise
por: Bartolomei, Mirco, et al.
Publicado: (2022)

Endoscopic ultrasound radiofrequency ablation of pancreatic insulinoma in elderly patients: Three case reports
por: Rossi, Gemma, et al.
Publicado: (2022)

Pancreatic ductal adenocarcinoma in 2017: Time to change the therapeutic algorithm?
por: Crippa, Stefano, et al.
Publicado: (2017)

Role of Endoscopic Ultrasound in the Diagnosis of Pancreatic Neuroendocrine Neoplasms
por: Ishii, Tatsuya, et al.
Publicado: (2021)

Narrative Review of Immunotherapy in Gastroentero-Pancreatic Neuroendocrine Neoplasms
por: Kaur, Jasmeet, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qpgiq2dathhb5123pgkqa47bc9